- Report
- March 2024
- 199 Pages
Global
From €3229EUR$3,374USD£2,744GBP
€3588EUR$3,749USD£3,049GBP
- Report
- February 2024
- 175 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- January 2024
- 200 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- December 2023
- 200 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- June 2024
- 94 Pages
Global
From €5360EUR$5,600USD£4,554GBP
- Report
- August 2023
- 180 Pages
Global
From €3589EUR$3,750USD£3,049GBP
- Report
- May 2024
- 133 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- January 2024
- 175 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- February 2024
- 120 Pages
Global
From €4546EUR$4,750USD£3,863GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1436EUR$1,500USD£1,220GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1436EUR$1,500USD£1,220GBP
- Report
- May 2024
- 129 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 133 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 134 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- March 2024
- 196 Pages
Global
From €3229EUR$3,374USD£2,744GBP
€3588EUR$3,749USD£3,049GBP
- Report
- September 2023
- 81 Pages
Global
From €5695EUR$5,950USD£4,838GBP
- Report
- September 2023
- 180 Pages
Global
From €5695EUR$5,950USD£4,838GBP
- Report
- February 2024
- 175 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- February 2024
- 179 Pages
Global
From €4690EUR$4,900USD£3,985GBP
- Report
- June 2023
- 143 Pages
Global
From €2392EUR$2,499USD£2,032GBP
The Hepatitis Drug market is a subset of the Infectious Diseases Drugs market, which includes treatments for a variety of illnesses caused by microorganisms. Hepatitis drugs are used to treat viral infections of the liver, including hepatitis A, B, and C. These drugs can be used to reduce symptoms, prevent further damage to the liver, and even cure the infection. Common treatments include antiviral medications, interferon, and direct-acting antivirals.
The Hepatitis Drug market is highly competitive, with many companies offering treatments for different types of hepatitis. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Bristol-Myers Squibb, and Novartis. Other companies such as Cipla, Mylan, and Teva Pharmaceuticals also offer treatments for hepatitis. Show Less Read more